HYTN Innovations Inc (TSE:HYTN) has released an update.
HYTN Innovations Inc., a pharmaceutical company known for producing psychoactive and psychotropic compounds, has achieved a significant milestone by obtaining an additional GMP certification that includes distribution for international markets. This expansion of its Kelowna manufacturing facility’s capabilities under its existing Drug Establishment Licence enables HYTN to distribute its non-sterile pharmaceutical products, such as cannabis medicines, directly to key markets globally.
For further insights into TSE:HYTN stock, check out TipRanks’ Stock Analysis page.